Sponsored Programs Administration

Limited Submission Announcement


Please follow the MU Limited Submission Procedures to be considered for a limited submission program.

Sponsor:

Department of Health and Human Services (HHS) | National Institutes of Health (NIH) | National Cancer Institute (NCI)

Announcement:

Pediatric Early Phase Clinical Trials Network (UM1)

Campus Deadline:

7/31/2017

External Deadline:

September 14, 2017

Web Address:

https://www.grants.gov/web/grants/view-opportunity.html?oppId=294514

Funding Amount:

Up to $3,600,000

Notes:

Only one application per institution is allowed.

The purpose of this Funding Opportunity Announcement (FOA) is to enhance NCI's program for conducting early phase clinical trials in children with cancer, currently supported as the Children's Oncology Group (COG) Phase 1 & Pilot Consortium. The overall goal is to ensure that high priority novel agents can be tested in pediatric patients in a timely manner. Towards this end, the clinical research activities now supported through the COG Phase 1 & Pilot Consortium will be continued (and enhanced) by the Pediatric Early Phase Clinical Trials Network (PEP-CTN).
 

Post Date: 07/11/17